发明名称 B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
摘要 <p>594275 Disclosed is a humanized CD37-specific binding protein comprising: (a) human light chain framework regions, a light chain CDR1 comprising an amino acid sequence of SEQ ID NO:61, or 62, a light chain CDR2 comprising an amino acid sequence of SEQ ID NO:64, and a light chain CDR3 comprising an amino acid sequence of SEQ ID NO:66; and (b) human heavy chain framework regions, a heavy chain CDR1 comprising an amino acid sequence of SEQ ID NO:63, a heavy chain CDR2 comprising an amino acid sequence of SEQ ID NO:65, and a heavy chain CDR3 comprising an amino acid sequence of SEQ ID NO: 67 or 68.</p>
申请公布号 NZ594275(A) 申请公布日期 2013.04.26
申请号 NZ20060594275 申请日期 2006.07.25
申请人 EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC 发明人 PETER ARMSTRONG THOMPSON;WILLIAM BRADY;MARTHA SUSAN HAYDEN-LEDBETTER;SANDY ALEXANDER SIMON;LAURA SUE GROSMAIRE;JEFFREY A
分类号 C12N5/10;A61K39/395;A61P21/04;A61P35/00;A61P37/00;C07K16/28;C07K16/46;C12N15/13;C12N15/85 主分类号 C12N5/10
代理机构 代理人
主权项
地址